Bioventus, Inc. (BVS)
8.97
-0.18
(-1.97%)
USD |
NASDAQ |
Apr 02, 16:00
8.955
-0.02
(-0.17%)
After-Hours: 20:00
Bioventus Profit Margin (Quarterly) : 10.97% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 15.71% |
| Accuray, Inc. | -13.47% |
| Alphatec Holdings, Inc. | -10.20% |
| Boston Scientific Corp. | 12.68% |
| Plus Therapeutics, Inc. | -417.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.53% |
| Return on Assets | 3.88% |
| Return on Invested Capital | 4.99% |
| Gross Profit Margin (Quarterly) | 68.07% |
| Operating Margin (Quarterly) | 13.75% |
| Return on Net Operating Assets | 4.21% |